Leukemia inhibitory factor as a regulator of steroidogenesis in human NCI-H295R adrenocortical cells

Journal of Endocrinology

Volumn 199, Issue 3, 2008, Pages 435-444

  Mikhaylova, Irina V ^a   Jääskeläinen, Tiina ^a   Jääskeläinen, Jarmo ^a   Palvimo, Jorma J ^a   Voutilainen, Raimo ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; 3BETA HYDROXYSTEROID DEHYDROGENASE 2; 8 BROMO CYCLIC AMP; ALDOSTERONE; ANDROSTENEDIONE; HYDROCORTISONE; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; PRASTERONE; PRASTERONE SULFATE; STEROID 17,20 LYASE; STEROID 17ALPHA MONOOXYGENASE; STEROIDOGENIC ACUTE REGULATORY PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ADRENAL CORTEX CELL; APOPTOSIS; ARTICLE; CELL ASSAY; CELL LINE; CELL VIABILITY; CONTROLLED STUDY; HORMONE DETERMINATION; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; STEROIDOGENESIS; WESTERN BLOTTING;

3-HYDROXYSTEROID DEHYDROGENASES; 8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ADRENAL CORTEX; ALDOSTERONE; ANDROSTENEDIONE; APOPTOSIS; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; GENE EXPRESSION REGULATION; HUMANS; HYDROCORTISONE; LEUKEMIA INHIBITORY FACTOR; PHOSPHOPROTEINS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEROID 17-ALPHA-HYDROXYLASE;

EID: 57449093536     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0377     Document Type: Article

References (50)

1. Akita S, Webster J, Ren SG, Takino H, Said J, Zand O & Melmed S 1995 Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion. Journal of Clinical Investigation 95 1288-1298.
2. Akita S, Conn PM & Melmed S 1996 Leukemia inhibitory factor (LIF) induces acute adrenocorticotrophic hormone (ACTH) secretion in fetal rhesus macaque primates: a novel dynamic test of pituitary function. Journal of Clinical Endocrinology and Metabolism 81 4170-4178.
3. Arakane F, King RR, Du Y, Kallen CB, Walsh LP, Watari H, Stocco DM & Strauss JF III 1997 Phosphorylation of steroidogenic acute regulatory protein (StAR) modulates its steroidogenic activity. Journal of Biological Chemistry 272 32656-32662.
4. Arici A, Engin O, Attar E & Olive DL 1995 Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in human endometrium. Journal of Clinical Endocrinology and Metabolism 80 1908-1915.
5. Auernhammer CJ & Melmed S 2000 Leukemia-inhibitory factor - neuroimmune modulator of endocrine function. Endocrine Reviews 21 313-345.
6. Auernhammer CJ, Chesnokova V & Melmed S 1998 Leukemia inhibitory factor modulates interieukin-1beta-induced activation ofthe hypothalamopituitary-adrenal axis. Endocrinology 139 2201-2208.
7. Azari MF, Profyris C, Karnezis T, Bernard CC, Small DH, Cheema SS, Ozturk E, Hatzinisiriou I & Petratos S 2006 Leukemia inhibitory factor arrests oligodendrocyte death and demyelination in spinal cord injury. Journal of Neuropathology and Experimental Neurology 65 914-929.
8. Bamberger AM, Schulte HM, Wullbrand A, Jung R, Beil FU & Bamberger CM 2000 Expression of leukemia inhibitory factor (LIF) and LIF receptor (LIF-R) in the human adrenal cortex: implications for steroidogenesis. Molecular and Cellular Endocrinology 162 145-149.
9. Barney M, Call GB, Mcllmoil CJ, Husein OF, Adams A, Balls AG, Oliveira GK, Miner EC, Richards TA, Crawford BK et al. 2000 Stimulation by interleukin-6 and inhibition by tumor necrosis factor of cortisol release from bovine adrenal zona fasciculata cells through their receptors. Endocrine 13 369-377.
10. Bousquet C, Ray DW & Melmed S 1997 A common pro-opiomelanocortin-binding element mediates leukemia inhibitory factor and corticotropin-releasing hormone transcriptional synergy. Journal of Biological Chemistry 272 10551-10557.
11. De Breuck S, Baeyens L & Bouwens L 2006 Expression and function of leukaemia inhibitory factor and its receptor in normal and regenerating rat pancreas. Diabetologia 49 108-116.
12. Campbell IK, Waring P, Novak U & Hamilton JA 1993 Production of leukemia inhibitory factor by human articular chondrocytes and cartilage in response to interleukin-1 and tumor necrosis factor alpha. Arthritis and Rheumatism 36 790-794.
13. Carter DA 1995 Leukaemia inhibitory factor expression in cultured rat anterior pituitary is regulated by glucocorticoids. Journal of Neuroendocrinology 7 623-628.
14. Chesnokova V & Melmed S 2002 Minineview: neuro-immuno-endocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gp130 signaling molecules. Endocrinology 143 1571-1574.
15. Chesnokova V, Auernhammer CJ & Melmed S 1998 Murine leukemia inhibitory factor gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress response. Endocrinology 139 2209-2216.
16. Chesnokova V, Kariagina A & Melmed S 2002 Opposing effects of pituitary leukemia inhibitory factor and SOCS-3 on the ACTH axis response to inflammation. American Journal of Physiology. Endocrinology and Metabolism 282 E1110-E1118.
17. Dhingra K, Sahin A, Emami K, Hottobagyi GN & Estrov Z 1998 Expression of leukemia inhibitory factor and its receptor in breast cancer: a potential autocrine and paracrine growth regulatory mechanism. Breast Cancer Research and Treatment 48 165-174.
18. Estrov Z, Samal B, Lapushin R, Kellokumpu-Lehtinen F, Sahin AA, Kurzrock R, Talpaz M & Aggarwal BB 1995 Leukemia inhibitory factor binds to human breast cancer cells and stimulates their proliferation. Journal of Interferon & Cytokine Research 15 905-913.
19. Ferrara N, Winer J & Henzel WJ 1992 Pituitary follicular cells secrete an inhibitor of aortic endothelial cell growth: identification as leukemia inhibitory factor. PNAS 89 698-702.
20. Gearing DP 1993 The leukemia inhibitory factor and its receptor. Advances in Immunology 53 31-58.
21. Grosser C, Jazwiec B, Taupin JL, Liu H, Richard S, Mahon FX, Reiffers J, Moreau JF & Ripoche J 1995 In vitro biosynthesis of leukemia inhibitory factor/human interleukin for DA cells by human endothelial cells: differential regulation by interleukin-1 alpha and glucocorticoids. Blood 86 3763-3770.
22. Hamilton JA, Waring PM & Filonzi EL 1993 Induction of leukemia inhibitory factor in human synovial fibroblasts by IL-1 and tumor necrosis factor-alpha. Journal of Immunology 150 1496-1502.
23. Hanisch A, Dieterich KD, Dietzmann K, Ludecke K, Buchfelder M, Fahlbusch R & Lehnert H 2000 Expression of members of the interleukin-6 family of cytokines and their receptors in human pituitary and pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 85 4411-4414.
24. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Müller-Newen G & Schaper F 2003 Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochemical Journal 374 1-20.
25. Hilton DJ, Nicola NA & Metcalf D 1988 Purification of a murine leukemia inhibitory factor from Krebs ascites cells. Analytical Biochemistry 173 359-367.
26. llvesmäki V, Jäättela M, Saksela E & Voutilainen R 1993 Tumor necrosis factor-alpha and interferon-gamma inhibit insulin-like growth factor II gene expression in human fetal adrenal cell cultures. Molecular and Cellular Endocrinology 91 59-65.
27. Jäättela M, Carpen O, Stenman UH & Saksela E 1990 Regulation of ACTH-induced steroidogenesis in human fetal adrenals by rTNF-a. Molecular and Cellular Endocrinology 68 R31-R36.
28. Jäättelä M, Ilvesmäki V, Voutilainen R, Stenman UH & Saksela E 1991 Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells. Endocrinology 128 623-629.
29. Judd AM, Call GB, Barney M, Mcllmoil CJ, Balls AG, Adams A & Oliveira GK 2000 Possible function of IL-6 and TNF as intraadrenal factors in the regulation of adrenal steroid secretion. Annals of the New York Academy of Sciences 917 628-637.
30. Kamohara H, Sakamoto K, Ishiko T, Masuda Y, Abe T & Ogawa M 1997 Leukemia inhibitory factor induces apoptosis and proliferation of human carcinoma cells through different oncogene pathways. International Journal of Cancer 72 687-695.
31. Kellokumpu-Lehtinen P, Talpaz M, Harris D, Van Q, Kurzrock R & Estrov Z 1996 Leukemia-inhibitory factor stimulates breast, kidney and prostate cancer cell proliferation by paracrine and autocrine pathways. International Journal of Cancer 66 515-519.
32. Lass A, Weiser W, Munafo A & Loumaye E 2001 Leukemia inhibitory factor in human reproduction. Fertility and Sterility 76 1091-1096.
33. Metcalf D & Gearing DP 1989 Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor. PNAS 86 5948-5952.
34. Mikhaylova IV, Kuulasmaa T, Jääskeläimen J & Voutilainen R 2007 Tumor necrosis faccor-alpha regulates steroidogenesis, apoptosis, and cell viability in the human adrenocortical cell line NCI-H295R. Endocrinology 148 386-392.
35. Mylonas I, Makovitzky J, Shabani N, Richter DU, Kuhn C, Jeschke U, Briese V & Friese K 2005 Leukaemia inhibitory factor (LIF) is immumohisto-chemically expressed in normal, hyperplastic and malignant endometrial tissue. European Journal of Obstetrics, Gynecology, and Reproductive Biology 118 101-108.
36. Paglia D, Oran A, Lu C, Kerbel RS, Sander DN & McKenzie RC 1995 Expression of leukemia inhibitory factor and interleukin-11 by human melanoma cell lines: LIF, IL-6, and IL-11 are not coregulated. Journal of Interferon & Cytokine Research 15 455-460.
37. Patterson PH 1994 Leukemia inhibitory factor, a cytokine at the interface between neurobiology and immunology. PNAS 91 7833-7835.
38. Rainey WE, Bird IM & Mason JI 1994 The NCI-H295 cell line: a pluripotent model for human adrenocortical studies. Molecular and Cellular Endocrinology 100 45-50.
39. Ray DW Ren SG & Melmed S 1996 Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway. Journal of Clinical Investigation 97 1852-1859.
40. Robinson RC, Grey LM, Staunton D, Vankelecom. H, Vernallis AB, Moreau JE Stuart DI, Heath JK & Jones EY 1994 The crystal structure and biological function of leukemia inhibitory factor: implications for receptor binding. Cell 77 1101-1116.
41. Samandari E, Kempná P, Nuoffer JM, Hofer G, Mullis PE & Flück CE 2007 Human adrenal corticocarcinoma NCI-H295R cells produce more androgens than NCI-H295A cells and differ in 3beta-hydroxysteroid dehydrogenase type 2 and 17,20 lyase activities. Journal of Endocrinology 195 459-472.
42. Savitz SI & Kessler JA 2000 Leukemia inhibitory factor requires concurrent p75LNTR signaling to induce apoptosis of cultured sympathetic neurons. Journal of Neuroscience 20 4198-4205.
43. Schere-Levy C, Buggiano V, Quaglino, A, Gatteli A, Cirio MC, Piazzon I, Vanzulli S & Kordon EC 2003 Leukemia inhibitory factor induces apoptosis of the mammary epithelial cells and participates in mouse mammary gland involution. Experimental Cell Research 282 35-47.
44. Shimon I, Yan X, Ray DW & Melmed S 1997 Cytokine-dependent gp130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion. Journal of Clinical Investigation 100 357-363.
45. Stahl N, Boulton TG, Farruggella T, Ip NY, Davis S, Witthuhn BA, Quelle FW, Silvennonin O, Barbieri G, Pellegrini S et al. 1994 Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science 263 92-95.
46. Vani S, McDonald SE, Williams AR, Mason JI, Thong KJ & Critchley HO 2007 Mid-luteal endometrial intracrinology following controlled ovarian hyperstimulation involving use of a gonadotrophin releasing hormone antagonist. Human Reproduction 22 2981-2991.
47. Vogiagis D & Salamonsen LA 1999 The role of leukaemia inhibitory factor in the establishment of pregnancy. Journal of Endocrinology 160 181-190.
48. Voutilainen R 1998 Adrenocortical cells are the site of secretion and action of insulin-like growth factors and TNF-alpha. Hormone and Metabolic Research 30 432-435.
49. Wang Z, Ren SG & Melmed S 1996 Hypothalamic and pituitary leukemia inhibitory factor gene expression in vivo: a novel endotoxin-inducible neuro-endocrine interface. Endocrinology 137 2947-2953.
50. Zhang XG, Go JJ, Lu ZY, Yasukawa K, Yancopoulos GD, Turner K, Shoyab M, Taga T, Kishimoto T, Bataille R et al. 1994 Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130. Journal of Experimental Medicine 179 1337-1342.